The global hirsutism market size is anticipated to reach USD 5.0 billion by 2030 and is anticipated to expand at a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market for hirsutism has been negatively affected by the COVID-19 pandemic, which is now widespread. According to the NCBI article in September 2021, a study by Yale et al. examined the connection between hyperandrogenic women, including those with polycystic ovary syndrome (PCOS), hirsutism, and COVID-19.
The study revealed that hospitalization among COVID-19-positive women with hyperandrogenism ranged from 4.5% to 8%, with no significant boost in mortality rates compared to 11.4%-11.7% in those without these conditions. In addition, the incidence of COVID-19 infection or hospitalization in these women did not appear to be significantly associated with their use of therapeutic agents, including spironolactone, estradiol, and metformin.
The demand for laser hair removal is growing, especially in the markets, due to an increasing number of cosmetic procedures and rising consciousness about beauty. Laser hair removal is the most commonly used solution for unwanted hair and its associated cosmetic and psychosomatic concerns as individuals strive for smooth, hairless skin. In 2022, hair removal procedures were a major part of aesthetic treatments, with over 1.8 million operations conducted by women and men, according to the International Society for Aesthetic Plastic Surgery. This increase in hair removal procedures highlights the demand for an effective and permanent solution to unwanted hair.
Request a free sample copy or view report summary: Hirsutism Market Report
Medications dominated the treatment type segment with more than 56.8% share in 2023, owing to birth control pills the most common medications used to treat hirsutism
The procedures segment is expected to grow at the fastest CAGR over the forecast period
The upper lip segment held the largest market share of 25.6% in 2023. The chin segment is anticipated to grow significantly over the forecast period. It is common for women to have light facial hair on the exterior corners of the jawline and upper lip, contributing to the growing prevalence of hirsutism
North America dominated the market for hirsutism owing to factors such as increasing the prevalence of hirsutism, high purchasing power parity, government support for quality healthcare, and availability of reimbursement
In October 2022, Sensus healthcare a medical device manufacturer specializing in highly effective, minimally-invasive, non-invasive, and cost-operative treatments for non-oncological conditions and oncological, introduced its movable silk by sensus hair removal system with blended wavelengths
Grand View Research has segmented the global hirsutism market based on treatment type, application, end-use, and region:
Hirsutism Treatment type Outlook (Revenue, USD Million, 2018 - 2030)
Medications
Procedures
Others
Hirsutism Application Outlook (Revenue, USD Million, 2018 - 2030)
Upper Lip
Chin
Chest
Arms
Others
Hirsutism End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Dermatology Clinics & Aesthetic Centers
Others
Hirsutism Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Hirsutism Market
Ajanta Pharma
Alma Lasers Ltd.
Alpaya Dermaceuticals
Cynosure Inc.
Lumenis Inc.
Nisim Inc.
Sciton International
Koninklijke Philips N.V
Merck & Co., Inc.
Pfizer Inc.
Cutera Inc.
El.En. S.p.A.
"The quality of research they have done for us has been excellent..."